Directory

>

Jagath Reddy Junutula

avatar

Jagath Reddy Junutula

Board Member | Aarvik Therapeutics Inc

Fremont, California, United States

View contact details (it's free)

Jagath Reddy Junutula

Summary

Jagath Reddy Junutula is an accomplished biochemist and molecular cell biologist with over 25 years of experience in life sciences and a focus on oncology drug discovery. He is the President, CEO, and Co-founder of Aarvik Therapeutics, where he leads innovative projects in antibody drug conjugates and therapeutic development. Jagath has developed a novel THIOMAB technology platform and has authored over 100 patents and peer-reviewed publications. His extensive background includes leadership roles in various organizations, including Genentech and Cellerant Therapeutics, where he oversaw significant research initiatives. He has received multiple awards for his contributions to the field, including recognition for key publications and advancements in antibody drug conjugate technology. Jagath is passionate about advancing cancer therapies and has a proven track record in cross-functional collaboration and project management.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Jagath Reddy Junutula

Work Experience

💼

Board Member at

EPOK Therapeutics Inc

August 2024 - Present

company logo

Co-founder, President & CEO at

Aarvik Therapeutics Inc

June 2021 - Present

company logo

Board Member at

Aarvik Therapeutics Inc

June 2021 - Present

company logo

Scientific Advisory Board Member at

NJ Bio, Inc.

October 2019 - Present

💼

Senior Vice President-R&D and Chief Development Officer (CDO) at

Antlera Therapeutics (u.s.) Corporation

August 2020 - May 2021

company logo

Co-founder at

NewCo

August 2020 - May 2021

💼

Scientific Advisory Board Member at

Antlera Therapeutics (u.s.) Corporation

November 2019 - July 2020

💼

Senior Vice President, Research & Development at

Modmab Therapeutics (u.s.) Corporation

December 2018 - July 2020

company logo

Vice President, Research & Development at

Cellerant Therapeutics, Inc.

April 2014 - November 2018

company logo

Senior Scientist/Group Leader at

Genentech Foundation

April 2001 - April 2014

company logo

President at

EPPIC Global

January 2010 - December 2011

company logo

Post Doctoral Fellow at

Leland Stanford Junior University

May 2000 - April 2001

💼

Alexander von Humboldt Fellow at

University Of Wittenherdecke

July 1997 - April 2000

Logos provided by Logo.dev

Jagath Reddy Junutula

Education

Indian Institute of Science, Ph.D.

January 1991 - January 1997

Osmania University, Ms

January 1989 - January 1991

Frequently Asked Questions about Jagath Reddy Junutula

What is Jagath Reddy Junutula email address?

Jagath Reddy Junutula's primary email address is ******@aarviktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Jagath Reddy Junutula work for?

Jagath Reddy Junutula is a Board Member at Aarvik Therapeutics Inc, a company specializing in Commercial physical research.

Where Jagath Reddy Junutula graduated from?

Jagath Reddy Junutula holds a degree in Biochemistry from Indian Institute of Science.

How can I directly contact Jagath Reddy Junutula?

To contact Jagath Reddy Junutula directly, you can use the email address ******@aarviktx.com. Complete contact information is available upon registration with Muraena.

Who is Jagath Reddy Junutula?

Jagath Reddy Junutula is an accomplished biochemist and molecular cell biologist with over 25 years of experience in life sciences and a focus on oncology drug discovery. He is the President, CEO, and Co-founder of Aarvik Therapeutics, where he leads innovative projects in antibody drug conjugates and therapeutic development. Jagath has developed a novel THIOMAB technology platform and has authored over 100 patents and peer-reviewed publications. His extensive background includes leadership roles in various organizations, including Genentech and Cellerant Therapeutics, where he oversaw significant research initiatives. He has received multiple awards for his contributions to the field, including recognition for key publications and advancements in antibody drug conjugate technology. Jagath is passionate about advancing cancer therapies and has a proven track record in cross-functional collaboration and project management.

Jagath`s contact details

mail

******@aarviktx.com

***************@njbio.com

Colleagues

avatar
Ram Reddy

Co-Founder, CEO, and Board Member

View Contact details (it's free)
Request Profile Removal